{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:55:23Z","timestamp":1788375323404,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pnpbp.2025.111300","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:20:15Z","timestamp":1740396015000},"page":"111300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey"],"prefix":"10.1016","volume":"137","author":[{"given":"B.","family":"Romeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kervadec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Strika-Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Amirouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Verroust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Piolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Benyamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2025.111300_bib237","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0091-3057(85)90022-X","article-title":"Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide","volume":"23","author":"Adams","year":"1985","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111300_bb0005","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111300_bb0010","article-title":"Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects","author":"Becker","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111300_bb0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.encep.2020.12.002","article-title":"Efficacy of psychedelics in psychiatry, a systematic review of the literature","volume":"47","author":"Berkovitch","year":"2021","journal-title":"L\u2019Encephale"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111300_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111300_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111300_bb0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.beth.2011.03.007","article-title":"Preliminary psychometric properties of the acceptance and action questionnaire\u2013II: a revised measure of psychological inflexibility and experiential avoidance","volume":"42","author":"Bond","year":"2011","journal-title":"Behav. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111300_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39812-0","article-title":"Improvement in OCD symptoms associated with serotoninergic psychedelics: a retrospective online survey","volume":"13","author":"Buot","year":"2023","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.pnpbp.2025.111300_bb0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2025.111300_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J. Contextual Behav. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111300_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/02698811211069103","article-title":"Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 \u03bcg LSD in healthy participants within a novel intervention paradigm: a proof-of-concept study","volume":"36","author":"Family","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111300_bb0055","first-page":"1","article-title":"Validation of a French version of the mystical experience questionnaire with retrospective reports of the Most significant psychedelic experience among French users","author":"Fauvel","year":"2022","journal-title":"J. Psychoactive Drugs"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111300_bb0060","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881119845793","article-title":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","volume":"33","author":"Garcia-Romeu","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111300_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111300_bib242","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","article-title":"Default mode Nnetwork modulation by psychedelics: A systematic review","volume":"26","author":"Gattuso","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111300_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/alcalc\/agab079","article-title":"Association between functional and structural brain connectivity of the default mode network in non-treatment seeking individuals with alcohol use disorder","volume":"57","author":"Gerhardt","year":"2022","journal-title":"Alcohol Alcohol."},{"issue":"18","key":"10.1016\/j.pnpbp.2025.111300_bb0075","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2025.111300_bb0080","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jad.2022.12.025","article-title":"Outcomes of acceptance and commitment therapy for depression and predictors of treatment response in veterans health administration patients","volume":"323","author":"Grau","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111300_bb0085","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111300_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111300_bb0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2018.00897","article-title":"Predicting responses to psychedelics: a prospective study","volume":"9","author":"Haijen","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111300_bb0100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111300_bb0105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/0269881121992676","article-title":"Dose\u2013response relationships of psilocybin-induced subjective experiences in humans","volume":"35","author":"Hirschfeld","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111300_bb0110","first-page":"1","article-title":"Dose-response relationships of LSD-induced subjective experiences in humans","author":"Hirschfeld","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111300_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, Placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111300_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/02698811231200019","article-title":"Assessment of the acute subjective psychedelic experience: a review of patient-reported outcome measures in clinical research on classical psychedelics","volume":"38","author":"Hovmand","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111300_bb0125","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111300_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111300_bb0135","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/0269881116684335","article-title":"An online survey of tobacco smoking cessation associated with naturalistic psychedelic use","volume":"31","author":"Johnson","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111300_bb0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-017-4820-5","article-title":"The hidden therapist: evidence for a central role of music in psychedelic therapy","volume":"235","author":"Kaelen","year":"2018","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111300_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/alcalc\/agad078","article-title":"Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey","volume":"59","author":"Kervadec","year":"2024","journal-title":"Alcohol Alcohol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111300_bib236","doi-asserted-by":"crossref","first-page":"24253","DOI":"10.1038\/s41598-024-75595-8","article-title":"Acceptance as a possible link between past psychedelic experiences and psychological flexibility","volume":"14","author":"Krabbe","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111300_bib239","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","article-title":"A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: The involvement of MAP kinases","volume":"86","author":"Kurrasch\u2010Orbaugh","year":"2003","journal-title":"J. Neurochem."},{"issue":"9\u201310","key":"10.1016\/j.pnpbp.2025.111300_bb0150","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00213-016-4453-0","article-title":"Alterations of consciousness and mystical-type experiences after acute LSD in humans","volume":"234","author":"Liechti","year":"2017","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111300_bb0155","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111300_bib238","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00213-002-1141-z","article-title":"Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats","volume":"164","author":"Marona-Lewicka","year":"2002","journal-title":"Psychopharmacology"},{"issue":"47","key":"10.1016\/j.pnpbp.2025.111300_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111300_bib243","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111300_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.erap.2009.09.001","article-title":"Traduction et validation fran\u00e7aise du questionnaire d\u2019acceptation et d\u2019action (AAQ-II)","volume":"59","author":"Monest\u00e8s","year":"2009","journal-title":"Eur. Rev. Appl. Psychol."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111300_bb0170","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/02698811221101061","article-title":"Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample","volume":"36","author":"Nygart","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111300_bb0175","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111300_bb0180","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41398-023-02690-1","article-title":"Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats","volume":"13","author":"Reinwald","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111300_bb0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychires.2021.03.002","article-title":"Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review","volume":"137","author":"Romeo","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111300_bb0190","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/02791072.2023.2227171","article-title":"Impact of a naturalistic psychedelic experience on smoking: a retrospective survey","volume":"55","author":"Romeo","year":"2023","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pnpbp.2025.111300_bb0200","first-page":"1","article-title":"Significant psychedelic experiences evaluated for mystical characteristics associated with Cannabis use reduction and psychological flexibility improvement: a naturalistic cross-sectional retrospective survey","author":"Romeo","year":"2024","journal-title":"J. Psychoactive Drugs"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111300_bb0205","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111300_bb0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2023.01.073","article-title":"Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics","volume":"326","author":"Simonsson","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111300_bib240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jnc.15540","article-title":"Molecular insights into psychedelic drug action","volume":"162","author":"Slocum","year":"2022","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111300_bb0215","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/0284185120923270","article-title":"Abnormal functional connectivity and effective connectivity between the default mode network and attention networks in patients with alcohol-use disorder","volume":"62","author":"Song","year":"2021","journal-title":"Acta Radiol."},{"key":"10.1016\/j.pnpbp.2025.111300_bb0220","article-title":"Minorities\u2019 diminished psychedelic returns: income and educations impact on whites, blacks, Hispanics, and Asians","author":"Vina","year":"2024","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"10.1016\/j.pnpbp.2025.111300_bb0225","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111300_bb0230","first-page":"215","article-title":"People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences","volume":"28","author":"Williams","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2025.111300_bb0235","article-title":"Dynamic connectivity patterns of resting-state brain functional networks in healthy individuals after acute alcohol intake","volume":"16","author":"Zhang","year":"2022","journal-title":"Front. Neurosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:28:13Z","timestamp":1762284493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":53,"alternative-id":["S0278584625000545"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111300","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111300"}}